West Pharmaceutical Services (WST) : Dorsey Wright Associates scooped up 2,669 additional shares in West Pharmaceutical Services during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 11, 2016. The investment management firm now holds a total of 41,211 shares of West Pharmaceutical Services which is valued at $3,115,552.West Pharmaceutical Services makes up approximately 1.57% of Dorsey Wright Associates’s portfolio.
Other Hedge Funds, Including , Fisher Asset Management reduced its stake in WST by selling 13,388 shares or 1.08% in the most recent quarter. The Hedge Fund company now holds 1,222,462 shares of WST which is valued at $92,418,127. West Pharmaceutical Services makes up approx 0.17% of Fisher Asset Management’s portfolio.Advisory Services Network reduced its stake in WST by selling 78 shares or 61.9% in the most recent quarter. The Hedge Fund company now holds 48 shares of WST which is valued at $3,621.First Mercantile Trust Co reduced its stake in WST by selling 2,470 shares or 22.54% in the most recent quarter. The Hedge Fund company now holds 8,488 shares of WST which is valued at $640,335. West Pharmaceutical Services makes up approx 0.09% of First Mercantile Trust Co’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in WST by selling 22,226 shares or 76.7% in the most recent quarter. The Hedge Fund company now holds 6,752 shares of WST which is valued at $499,445.Independent Portfolio Consultants reduced its stake in WST by selling 6,270 shares or 53.14% in the most recent quarter. The Hedge Fund company now holds 5,530 shares of WST which is valued at $409,054. West Pharmaceutical Services makes up approx 0.13% of Independent Portfolio Consultants’s portfolio.
West Pharmaceutical Services closed down -1.43 points or -1.89% at $74.17 with 5,62,082 shares getting traded on Tuesday. Post opening the session at $75.44, the shares hit an intraday low of $73.64 and an intraday high of $75.44 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, West Pharmaceutical Services reported $0.60 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.56. The company had revenue of $388.00 million for the quarter, compared to analysts expectations of $384.58 million. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.47 EPS.
Investors should note that on Sep 12, 2016, West Pharmaceutical Services announced a cash dividend of $0.1300. The company’s management has announced Oct 17, 2016 as the ex-dividend date and fixed the record date on Oct 19, 2016. The payable date has been fixed on Nov 2, 2016.
Many Wall Street Analysts have commented on West Pharmaceutical Services. West Pharmaceutical Services was Downgraded by Wells Fargo to ” Market Perform” on Sep 21, 2016.
West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).